Dr. Alan Tita shares the results of the CHAP trial, which showed that treatment of mild chronic hypertension in pregnant women to a BP goal of <140/90 mmHg reduces adverse pregnancy outcomes and does not impair fetal growth.
Dr. Alan Tita shares the results of the CHAP trial, which showed that treatment of mild chronic hypertension in pregnant women to a BP goal of <140/90 mmHg reduces adverse pregnancy outcomes and does not impair fetal growth.